Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pharmakon Advisors

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.